Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Duffy

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
Clinical Chemistry|June 13, 1998
Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative diseaseM J Duffy, C Duggan, H E Mulcahy, et al.
Cancer|December 15, 1992
CA 15-3 in patients with locoregional and metastatic breast carcinomaJ G Geraghty, E C Coveney, F Sherry, et al.
Irish Journal of Medical Science|December 1, 1980
Carcino-embryonic antigen assay as a guide to tumour bulk, response to therapy and prognosis in human breast cancerB Cantwell, M J Duffy, J J Fennelly, et al.
British Journal of Cancer|July 4, 1998
Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistryS Kennedy, M J Duffy, C Duggan, et al.
Cancer Research|November 1, 1990
Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancerM J Duffy, D Reilly, C O'Sullivan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 5, 1982
The free T3 index in familial TBG deficiencyR J Farrell, M J Duffy, G J Duffy, et al.
Cancer|January 1, 1983
CEA-like material in cytosols from human breast carcinomas. Correlation with biochemical and pathologic parametersM J Duffy, M O'Connell, F O'Sullivan, et al.
Cancer|January 5, 1999
Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinomaS G Shering, F Sherry, E W McDermott, et al.
Clinical Chemistry|August 1, 1992
Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancerA Nugent, E McDermott, K Duffy, et al.
International Journal of Cancer|May 29, 1995
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancerC Duggan, T Maguire, E McDermott, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
Clinical Chemistry|June 13, 1998
Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative diseaseM J Duffy, C Duggan, H E Mulcahy, et al.
Cancer|December 15, 1992
CA 15-3 in patients with locoregional and metastatic breast carcinomaJ G Geraghty, E C Coveney, F Sherry, et al.
Irish Journal of Medical Science|December 1, 1980
Carcino-embryonic antigen assay as a guide to tumour bulk, response to therapy and prognosis in human breast cancerB Cantwell, M J Duffy, J J Fennelly, et al.
British Journal of Cancer|July 4, 1998
Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistryS Kennedy, M J Duffy, C Duggan, et al.
Cancer Research|November 1, 1990
Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancerM J Duffy, D Reilly, C O'Sullivan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 5, 1982
The free T3 index in familial TBG deficiencyR J Farrell, M J Duffy, G J Duffy, et al.
Cancer|January 1, 1983
CEA-like material in cytosols from human breast carcinomas. Correlation with biochemical and pathologic parametersM J Duffy, M O'Connell, F O'Sullivan, et al.
Cancer|January 5, 1999
Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinomaS G Shering, F Sherry, E W McDermott, et al.
Clinical Chemistry|August 1, 1992
Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancerA Nugent, E McDermott, K Duffy, et al.
International Journal of Cancer|May 29, 1995
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancerC Duggan, T Maguire, E McDermott, et al.
Pageof 17